Wed Oct 15 05:09:45 UTC 2025: ## News Article: Telangana Mandates Strict Testing for Cough Syrups After Adulteration Concerns

**Hyderabad, October 15, 2025** – In response to recent concerns surrounding the safety of cough syrups, particularly for children, the Telangana Drugs Control Administration (DCA) has implemented stringent new regulations. Effective immediately, all syrup manufacturers in the state are required to conduct rigorous testing for the presence of Diethylene Glycol (DEG) and Ethylene Glycol (EG) at every stage of the manufacturing process.

This decisive action follows reports of child deaths in Madhya Pradesh’s Chhindwara district, allegedly linked to adulterated cough syrups containing DEG. The DCA held a virtual meeting with all syrup manufacturers on October 10th to outline the new directives.

Key aspects of the new regulations include:

* **Direct Procurement:** Manufacturers must source pharmaceutical aids and excipients, such as glycerin, propylene glycol, and sorbitol solution, directly from the original manufacturers.
* **Pharmacopoeial Standards:** All raw materials must meet pharmacopoeial standards, with only pharmacopoeial-grade excipients permitted in production.
* **Mandatory Testing:** Prior to use, all raw materials must be tested for DEG and EG, with a permissible limit of 0.10% as per pharmacopoeial monographs. Manufacturers must sample and test every individual container or pack of excipients upon receipt.
* **Finished Product Testing:** All finished liquid oral products must be tested for DEG and EG, adhering to the amendment to the Indian Pharmacopoeia 2022, dated October 10.
* **Verifiable Testing:** The DCA insists on authentic and verifiable testing, even when outsourced to approved laboratories, to ensure the absence of DEG and EG.

The DCA will conduct unannounced inspections of manufacturing facilities to ensure compliance with these new directives. This proactive measure underscores the administration’s commitment to safeguarding public health and preventing the distribution of potentially harmful medications.

Read More